期刊文献+

胃癌中MCM5蛋白的表达及临床病理意义

Expressions and clinicopathological significance of MCM5 in gastric carcinoma
下载PDF
导出
摘要 目的探讨胃癌中微小染色体维持蛋白5(MCM5)的表达情况及临床病理意义。方法采用免疫组化SP法检测60例胃原发癌组织及20例正常胃黏膜组织(取自癌旁正常胃黏膜)中MCM5蛋白的表达情况,并结合临床病理参数进行综合分析。结果 MCM5在60例胃癌组织中阳性率为80.6%;在20例正常胃黏膜组织中阳性率为30%。胃癌组显著高于正常组(P<0.01)。MCM5在胃癌组中的表达与病理分级和浸润深度(T分期)有关(P<0.01;P<0.05)。结论 MCM5参与了胃癌的发生发展并可能作用于胃癌的早期阶段,其表达水平可能与胃癌病理分级、分期有关,检测其表达水平对胃癌的治疗选择和评估预后可能有重要的参考意义。 Objective To evaluate the expression of minichromosome maintenance protein 5(mcm5) in gastric carcinoma and its clinicopathological significance .Methods SP immunohistochemical stain was used to detect its expression in sample of 60 gastric cancer tissues and 20 normalgastric mucosa near the tumor .And their corresponding clinical data were comprehensive analyzed .Results The positive expression rates of mcm 5 was 80.6%in 60 gastric carcinoma and was 30%in normaltissues.Mcm5had notable differences between the gastric cancer tissues and nor-malgastric mucosa(P〈0.01).The expression of mcm5 was closely relevant to the grade and the invasive depth(P〈0.01;P〈0.05).Conclusions The expression of mcm5 is correlated to occurrence and development of gastric carcinoma .And it may work in the early phase in carcinogenesis of gastric carcinoma . The expression of Mcm5 is may also correlated to the grade and invasive depth and the detection of mcm 5 may have important reference significance in evaluating prognosis and guiding chemotherapy in patients with gastric carcinoma.
作者 孙志超
出处 《齐齐哈尔医学院学报》 2014年第18期2658-2659,共2页 Journal of Qiqihar Medical University
关键词 胃癌 微小染色体维持蛋白5 免疫组织化学 诊断 治疗 预后 Gastric carcinoma Minichromosome maintenance protein 5 Immunohistochemistry Diagnosis Therapy Prognosis
  • 相关文献

参考文献10

  • 1Giaginis C, Georgiadou M, Dimakopoulou K, et al. Clinical Significance of MCM-2 and MCM-5 Expression in Colon Cancer: Association with Clinicopathological Parameters and Tumor Proliferative Capacity [ J ]. Dig Dis Sci,2009,54 ( 2 ) : 282 -291.
  • 2石喆,任占平.肺腺癌组织中MCM5蛋白的表达及其意义[J].诊断病理学杂志,2008,15(5):405-407. 被引量:2
  • 3Williams GH, Swinn R, Prevost AT, De Clive-Eowe P, er al. Diagnosis of oesophageal cancer by detection of minichromosome maintenance 5 protein in gastric aspirates[ J]. Br J Cancer,2004, 91 (4) :714-719.
  • 4Kebebew E, Peng M, Reiff E, et al. Diagnostic and prognostic value of cell-cycle regulatory genes in malignant thyroid neoplasms [ J ]. World J Surg,2006,30 ( 5 ) :767-774.
  • 5张磊,汪素文,高薇,田斌,尹朝.MCM5和E2F-1在胃癌组织中的表达及临床病理意义[J].中国现代普通外科进展,2009,12(11):943-946. 被引量:1
  • 6高阳,刘永刚,庄竟,张永超.MCM5在贲门癌组织中的表达及临床意义[J].山东医药,2008,48(19):66-67. 被引量:2
  • 7Maiorano D, Lutzmann M, Mechali M. MCM proteins and DNA replication [ J ]. Currret Opinion in Cell Biology,2006,18 (2) : 130- 136.
  • 8Nathan A Steere, Satoru Yamaguchi, Catherine A Andrews,et al. Functional screen of human MCM2-7 variant alleles for disease- causing potential. Mutat Res, 2009,666 ( 1-2 ) :74 -78.
  • 9Schaarschmidt D, Ladenburger EM, KeLler C, et al. Human MCM proteins at a replication origin during the G1 to S phase transition [ J]. Nucleic Acids Res,2002,30(19) :4176-4185.
  • 10张磊,吴慧丽,李琨琨,肖兴国.微小染色体维持蛋白5在胃癌、癌前病变及正常胃黏膜组织中的表达及临床病理学意义[J].新乡医学院学报,2014,31(3):191-194. 被引量:2

二级参考文献35

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1365
  • 2任占平.微小染色体维持蛋白与肿瘤[J].诊断病理学杂志,2004,11(6):427-429. 被引量:12
  • 3夏可义,肖强,陆云飞,廖清华,黄源,林坚.胃癌中E2F-1的表达及其临床意义[J].中国肿瘤临床与康复,2005,12(2):124-126. 被引量:2
  • 4滕淑静,唐圣松.微小染色体维持蛋白与复制[J].南华大学学报(医学版),2007,35(2):283-286. 被引量:2
  • 5王静,马金龙,王强修,刘莹.微小染色体维持蛋白5在甲状腺肿瘤中的表达与意义[J].中国现代普通外科进展,2007,10(3):251-253. 被引量:2
  • 6Schaarschmidt D, Ladenburger EM, Keller C, et al. Human MCM proteins at a replication origin during the G1 to S phase transition[J]. Nucleic Acids Res,2002,30(19):4176- 4185.
  • 7Lawson JS, Tran D, Rawlinson WD. From Bittner to Barr: a viral, diet and hormone breast cancer aetiology hypothesis [ J ]. Breast Cancer Res, 2001,3(2) :81 - 85.
  • 8Yu Z, Feng D, Liang C. Pairwise interactions of the six human MCM protein subunits[J]. J Mol Biol, 2004, 340(5): 1197- 1206.
  • 9Rodins K, Cheale M, Coleman N, et al. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility[J]. Clin Cancer Res,2002,8(4) : 1075 - 1081.
  • 10Kato H, Miyazaki T, Fukai Y, et al. A new proliferation marker, minichromosome maintenance protein 2, is associated with tumor aggressiveness in esophageal squamous cell carcinoma [ J]. J Surg Oncol, 2003,84(1 ) :24 - 30.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部